Expression of concern reaffirmed. [N Engl J Med. 2006] - PubMed Result

Search for

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: N Engl J Med. 2006 Mar 16;354(11):1193. Epub 2006 Feb 22. Links

Comment in:: N Engl J Med. 2006 Mar 16;354(11):1196-9.
Comment on:: N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528.; N Engl J Med. 2005 Dec 29;353(26):2813-4.

Expression of concern reaffirmed.

Curfman GD, Morrissey S, Drazen JM.

PMID: 16495386 [PubMed - indexed for MEDLINE]

Related Articles

Response to expression of concern regarding VIGOR study. [N Engl J Med. 2006]
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8. [N Engl J Med. 2005]
Response to expression of concern regarding VIGOR study. [N Engl J Med. 2006]
The lessons of Vioxx--drug safety and sales. [N Engl J Med. 2005]
Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis. [Am J Med. 2004]
» See all Related Articles...

Patient Drug Information

Naproxen (Aleve®, Anaprox®, Anaprox® DS, ...) Prescription naproxen is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swellin...

» read more ...

Display Show